Cargando…
Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease for a multitude of reasons including very late diagnosis. This in part is due to the lack of understanding of the biological behavior of PDAC and the ineffective screening for this disease. Significant efforts have been dedicated to...
Autores principales: | Chang, John C., Kundranda, Madappa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372679/ https://www.ncbi.nlm.nih.gov/pubmed/28335509 http://dx.doi.org/10.3390/ijms18030667 |
Ejemplares similares
-
Infection Masquerading as Recurrence of Pancreatic Ductal Adenocarcinoma: A Cautionary Tale
por: Arivazhagan, Sowbharnika, et al.
Publicado: (2021) -
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
por: Kundranda, Madappa N, et al.
Publicado: (2015) -
When the Tumor Lyses: A Case Report on Spontaneous Tumor Lysis Syndrome
por: Dong, Jiaxi, et al.
Publicado: (2020) -
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
por: Park, Peter Y., et al.
Publicado: (2015) -
Metastatic Breast Cancer with Extensive Osseous Metastasis Presenting with Symptomatic Immune Thrombocytopenic Purpura and Anemia: A Case Report and Review of the Literature
por: Niu, Jiaxin, et al.
Publicado: (2015)